journal article·2002-04-01

Fluoroquinolone−Biomembrane Interaction at the DPPC/PG Lipid−Bilayer Interface

Sandra Merino, José Luis Vázquez, Òscar Domènech, Mercedes Berlanga, Miquel Viñas, M. Teresa Montero, Jordi Hernández-Borrell

Langmuir· Volume 18· Issue 8
Publisher page

Abstract

The interaction of two fluoroquinolones, ciprofloxacin (CPX) and its N -4-butylpiperazinyl derivative (BCPX), with liposomes bearing negative surface charge was studied by fluorescence methods. Binding of 1-anilino-8-naphthalenesulfonate to the liposome surface and diphenylhexatriene (DPH) and diphenylhexatriene−propionic (DPH−AP) acid fluorescence anisotropy measurements were differently affected by the two. On the basis of the variations of the surface potential and phase transition temperature ( T m ) of the phospholipids studied, it was concluded that (i) both drugs interact electrostatically at the lipid membrane interface and (ii) the butyl side chain of BCPX led to a different interaction with the lipid headgroups. This behavior is then related to the activity of an efflux pump Serratia marcescens NIMA, which appear to be affected by the ability of CPX and BCPX to interact with the inner surface of the plasma membrane.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Antibiotics Pharmacokinetics and Efficacy · Drug Transport and Resistance Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratori V de Fisicoquímica, Facultat de Farmàcia, U.B. 08028-Barcelona, Spain, and Laboratori de Microbiologia, Campus de Bellvitge, U.B. 08907-L'Hospitalet de Llobregat, Spain

References (19)

Show source-provided references
1. Van Veen H. W. · Biochim. Biophys. Acta · 1999 · 1461 · 206
2. Renau T. E. · J. Med. Chem. · 1995 · 38 · 297710.1021/jm00015a021 ↗
3. Takenouchi T. · Antimicrob. Agents Chemother. · 1996 · 40 · 184210.1128/AAC.40.8.1835 ↗
4. Putman M. · Microb. Mol. Biol. Rev. · 2000 · 64 · 69310.1128/MMBR.64.4.672-693.2000 ↗
5. Maurer N. · Biochim. Biophys. Acta · 1998 · 1374 · 20
6. Vázquez J. L. · Langmuir · 2001 · 17 · 101410.1021/la0008582 ↗
7. Nag K. · J. Liposome Res. · 1996 · 6 · 736
8. Majumdar S. · Antimicrob. Agents Chemother. · 1992 · 36 · 281510.1128/AAC.36.12.2808 ↗
9. Takacks-Novak K. · J. Pharm. Sci. · 1990 · 79 · 1028
10. Vázquez J. L. · Photochem. Photobiol. · 2001 · 73 · 19
11. Vázquez J. L. · Int. J. Pharm. · 2001 · 220 · 6210.1016/S0378-5173(01)00646-9 ↗
12. Hernández-Borrell J. · J. Chem. Educ. · 1996 · 74 · 1314
13. Montero M. T. · Int. J. Pharm. · 1997 · 149 · 17010.1016/S0378-5173(97)04866-7 ↗
14. Montero M. T. · Anal. Chim. Acta · 1993 · 290 · 64
15. Tiefenbacher E. M. · J. Pharm. Sci. · 1994 · 83 · 46710.1002/jps.2600830403 ↗
16. Williams R. R. · 1980 · 75
17. Ma J. Y. C. · J. Lipid Res. · 1985 · 26 · 744
18. Berlanga M. · Microb. Drug Resist. · 2000 · 6 · 11710.1089/107662900419410 ↗
19. Edgar R. · EMBO J. · 1999 · 18 · 83210.1093/emboj/18.4.822 ↗